Thursday, November 19, 2009

Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia

This study is currently recruiting participants.

First Received: November 18, 2009   No Changes Posted
Sponsor:
H. Lundbeck A/S
Information provided by:
H. Lundbeck A/S
ClinicalTrials.gov Identifier:
NCT01016366

No comments:

Post a Comment